Correlation of cadherin-17 protein expression with clinicopathological features and prognosis of patients with sporadic gastric cancer
This study aimed to explore the correlations between cadherin-17 (CDH17) protein expression and the clinicopathological features and prognosis of patients with sporadic gastric cancer (GC). Nine relevant studies of 1,960 patients were identified using electronic database searches supplemented with a manual search in strict accordance with inclusion and exclusion criteria. Statistical analyses were conducted using STATA 12.0 statistical software. Relative risks and 95% confidence intervals were determined, and Z test was used to measure the significance of the overall effect size. A total of nine eligible cohort studies were included in this meta-analysis. The expression of CDH17 in patients with diffuse GC was significantly higher than in those with intestinal-type GC. Moreover, the tumor depth of invasion differed significantly between patients with positive CDH17 (CDH17+) and negative CDH17 (CDH17-) GC. However, there were no significant differences between CDH17+ and CDH17- GC patients with respect to tumor node metastasis clinical stages, histological grades, or lymph node metastasis. Despite the differences in invasive depth, there was no significant difference in 5-year survival rates between CDH17+ and CDH17- GC patients. Our meta-analysis provides evidence that CDH17 protein expression may be associated with the development of GC, suggesting that CDH17 is an important biomarker that could be useful for the early diagnosis of GC. However, CDH17 levels do not appear to impact overall survival.
Main Authors: | , , , , , , |
---|---|
Format: | Digital revista |
Language: | English |
Published: |
Associação Brasileira de Divulgação Científica
2015
|
Online Access: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2015001201077 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
oai:scielo:S0100-879X2015001201077 |
---|---|
record_format |
ojs |
spelling |
oai:scielo:S0100-879X20150012010772019-03-18Correlation of cadherin-17 protein expression with clinicopathological features and prognosis of patients with sporadic gastric cancerMeng,W.Gu,T.Gao,L. M.Zong,Z. G.Meng,L.Fu,Z. Z.Guo,L. Cadherin-17 Gastric cancer Clinicopathological features Prognosis Meta-analysis Cohort study This study aimed to explore the correlations between cadherin-17 (CDH17) protein expression and the clinicopathological features and prognosis of patients with sporadic gastric cancer (GC). Nine relevant studies of 1,960 patients were identified using electronic database searches supplemented with a manual search in strict accordance with inclusion and exclusion criteria. Statistical analyses were conducted using STATA 12.0 statistical software. Relative risks and 95% confidence intervals were determined, and Z test was used to measure the significance of the overall effect size. A total of nine eligible cohort studies were included in this meta-analysis. The expression of CDH17 in patients with diffuse GC was significantly higher than in those with intestinal-type GC. Moreover, the tumor depth of invasion differed significantly between patients with positive CDH17 (CDH17+) and negative CDH17 (CDH17-) GC. However, there were no significant differences between CDH17+ and CDH17- GC patients with respect to tumor node metastasis clinical stages, histological grades, or lymph node metastasis. Despite the differences in invasive depth, there was no significant difference in 5-year survival rates between CDH17+ and CDH17- GC patients. Our meta-analysis provides evidence that CDH17 protein expression may be associated with the development of GC, suggesting that CDH17 is an important biomarker that could be useful for the early diagnosis of GC. However, CDH17 levels do not appear to impact overall survival.info:eu-repo/semantics/openAccessAssociação Brasileira de Divulgação CientíficaBrazilian Journal of Medical and Biological Research v.48 n.12 20152015-12-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2015001201077en10.1590/1414-431x20154645 |
institution |
SCIELO |
collection |
OJS |
country |
Brasil |
countrycode |
BR |
component |
Revista |
access |
En linea |
databasecode |
rev-scielo-br |
tag |
revista |
region |
America del Sur |
libraryname |
SciELO |
language |
English |
format |
Digital |
author |
Meng,W. Gu,T. Gao,L. M. Zong,Z. G. Meng,L. Fu,Z. Z. Guo,L. |
spellingShingle |
Meng,W. Gu,T. Gao,L. M. Zong,Z. G. Meng,L. Fu,Z. Z. Guo,L. Correlation of cadherin-17 protein expression with clinicopathological features and prognosis of patients with sporadic gastric cancer |
author_facet |
Meng,W. Gu,T. Gao,L. M. Zong,Z. G. Meng,L. Fu,Z. Z. Guo,L. |
author_sort |
Meng,W. |
title |
Correlation of cadherin-17 protein expression with clinicopathological features and prognosis of patients with sporadic gastric cancer |
title_short |
Correlation of cadherin-17 protein expression with clinicopathological features and prognosis of patients with sporadic gastric cancer |
title_full |
Correlation of cadherin-17 protein expression with clinicopathological features and prognosis of patients with sporadic gastric cancer |
title_fullStr |
Correlation of cadherin-17 protein expression with clinicopathological features and prognosis of patients with sporadic gastric cancer |
title_full_unstemmed |
Correlation of cadherin-17 protein expression with clinicopathological features and prognosis of patients with sporadic gastric cancer |
title_sort |
correlation of cadherin-17 protein expression with clinicopathological features and prognosis of patients with sporadic gastric cancer |
description |
This study aimed to explore the correlations between cadherin-17 (CDH17) protein expression and the clinicopathological features and prognosis of patients with sporadic gastric cancer (GC). Nine relevant studies of 1,960 patients were identified using electronic database searches supplemented with a manual search in strict accordance with inclusion and exclusion criteria. Statistical analyses were conducted using STATA 12.0 statistical software. Relative risks and 95% confidence intervals were determined, and Z test was used to measure the significance of the overall effect size. A total of nine eligible cohort studies were included in this meta-analysis. The expression of CDH17 in patients with diffuse GC was significantly higher than in those with intestinal-type GC. Moreover, the tumor depth of invasion differed significantly between patients with positive CDH17 (CDH17+) and negative CDH17 (CDH17-) GC. However, there were no significant differences between CDH17+ and CDH17- GC patients with respect to tumor node metastasis clinical stages, histological grades, or lymph node metastasis. Despite the differences in invasive depth, there was no significant difference in 5-year survival rates between CDH17+ and CDH17- GC patients. Our meta-analysis provides evidence that CDH17 protein expression may be associated with the development of GC, suggesting that CDH17 is an important biomarker that could be useful for the early diagnosis of GC. However, CDH17 levels do not appear to impact overall survival. |
publisher |
Associação Brasileira de Divulgação Científica |
publishDate |
2015 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2015001201077 |
work_keys_str_mv |
AT mengw correlationofcadherin17proteinexpressionwithclinicopathologicalfeaturesandprognosisofpatientswithsporadicgastriccancer AT gut correlationofcadherin17proteinexpressionwithclinicopathologicalfeaturesandprognosisofpatientswithsporadicgastriccancer AT gaolm correlationofcadherin17proteinexpressionwithclinicopathologicalfeaturesandprognosisofpatientswithsporadicgastriccancer AT zongzg correlationofcadherin17proteinexpressionwithclinicopathologicalfeaturesandprognosisofpatientswithsporadicgastriccancer AT mengl correlationofcadherin17proteinexpressionwithclinicopathologicalfeaturesandprognosisofpatientswithsporadicgastriccancer AT fuzz correlationofcadherin17proteinexpressionwithclinicopathologicalfeaturesandprognosisofpatientswithsporadicgastriccancer AT guol correlationofcadherin17proteinexpressionwithclinicopathologicalfeaturesandprognosisofpatientswithsporadicgastriccancer |
_version_ |
1756391507600867328 |